GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (STU:ECX) » Definitions » Pre-Tax Income

Epigenomics AG (STU:ECX) Pre-Tax Income : €-16.37 Mil (TTM As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Epigenomics AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Epigenomics AG's pretax income for the three months ended in Jun. 2023 was €-2.63 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was €-16.37 Mil. Epigenomics AG's pretax margin was -3,760.00%.

During the past 13 years, Epigenomics AG's highest Pretax Margin was -38.85%. The lowest was -3653.35%. And the median was -574.95%.


Epigenomics AG Pre-Tax Income Historical Data

The historical data trend for Epigenomics AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Pre-Tax Income Chart

Epigenomics AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.43 -14.57 -11.66 -2.41 -12.10

Epigenomics AG Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.30 -1.56 -6.58 -5.59 -2.63

Competitive Comparison of Epigenomics AG's Pre-Tax Income

For the Diagnostics & Research subindustry, Epigenomics AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigenomics AG's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Pre-Tax Income falls into.



Epigenomics AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Epigenomics AG's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-12.859+0+-0.13+0.099+0.789
=-12.10

Epigenomics AG's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.772+0+-0.007+0.009+0.138
=-2.63

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epigenomics AG  (STU:ECX) Pre-Tax Income Explanation

Epigenomics AG's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-2.632/0.07
=-3,760.00%

During the past 13 years, Epigenomics AG's highest Pretax Margin was -38.85%. The lowest was -3653.35%. And the median was -574.95%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epigenomics AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigenomics AG (STU:ECX) Business Description

Traded in Other Exchanges
Address
Geneststrasse 5, Berlin, BB, DEU, 10829
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.